Aull & Monroe Investment Management Corp Pfizer Inc Transaction History

Aull & Monroe Investment Management Corp

$184 Million
Q2 2025

A detailed history of Aull & Monroe Investment Management Corp transactions in Pfizer Inc stock. As of the latest transaction made, Aull & Monroe Investment Management Corp holds 40,265 shares of PFE stock, worth $975,620. This represents 0.53% of its overall portfolio holdings.

Number of Shares

40,265

Previous 46,365 13.16%

Holding current value

$975,620

Previous $1.17 Million 16.87%

% of portfolio

0.53%

Previous 0.59%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	SELL	$21.59 - $24.84 $131,699 - $151,524	-6,100 Reduced 13.16%	40,265 $976,000
Q1 2025 May 14, 2025	SELL	$25.01 - $27.13 $55,997 - $60,744	-2,239 Reduced 4.61%	46,365 $1.17 Million
Q4 2024 Feb 06, 2025	SELL	$24.8 - $30.19 $141,211 - $171,901	-5,694 Reduced 10.49%	48,604 $1.29 Million
Q3 2024 Oct 31, 2024	SELL	$27.7 - $31.39 $44,569 - $50,506	-1,609 Reduced 2.88%	54,298 $1.57 Million
Q2 2024 Jul 19, 2024	SELL	$25.26 - $29.6 $124,582 - $145,987	-4,932 Reduced 8.11%	55,907 $1.56 Million
Q1 2024 May 06, 2024	SELL	$25.89 - $29.73 $92,323 - $106,017	-3,566 Reduced 5.54%	60,839 $1.69 Million
Q4 2023 Jan 25, 2024	SELL	$26.13 - $33.94 $82,440 - $107,080	-3,155 Reduced 4.67%	64,405 $1.85 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $19,254 - $22,506	-600 Reduced 0.88%	67,560 $2.24 Million
Q2 2023 Jul 24, 2023	SELL	$36.12 - $41.79 $18,060 - $20,895	-500 Reduced 0.73%	68,160 $2.5 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $60,345 - $78,560	-1,532 Reduced 2.18%	68,660 $2.8 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $79,325 - $103,550	-1,900 Reduced 2.64%	70,192 $3.6 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $96,272 - $117,524	-2,200 Reduced 2.96%	72,092 $3.16 Million
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $5,769 - $6,841	-124 Reduced 0.17%	74,292 $3.9 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $11,437 - $14,172	-250 Reduced 0.33%	74,416 $3.85 Million
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $63,839 - $94,631	-1,545 Reduced 2.03%	74,666 $4.41 Million
Q2 2021 Jul 28, 2021	BUY	$35.91 - $40.68 $45,246 - $51,256	1,260 Added 1.68%	76,211 $2.98 Million
Q1 2021 Apr 19, 2021	BUY	$33.49 - $37.77 $88,748 - $100,090	2,650 Added 3.67%	74,951 $2.72 Million
Q4 2020 Feb 02, 2021	BUY	$33.47 - $42.56 $683,089 - $868,607	20,409 Added 39.33%	72,301 $2.66 Million
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $15,875 - $18,625	500 Added 0.97%	51,892 $1.91 Million
Q2 2020 Jul 28, 2020	SELL	$30.12 - $36.54 $38,764 - $47,026	-1,287 Reduced 2.44%	51,392 $1.68 Million
Q1 2020 Apr 22, 2020	BUY	$27.03 - $38.62 $8,568 - $12,242	317 Added 0.61%	52,679 $1.72 Million
Q4 2019 Feb 04, 2020	SELL	$32.92 - $37.36 $9,876 - $11,208	-300 Reduced 0.57%	52,362 $2.05 Million
Q3 2019 Oct 30, 2019	SELL	$32.49 - $42.13 $109,718 - $142,273	-3,377 Reduced 6.03%	52,662 $1.89 Million
Q2 2019 Jul 29, 2019	SELL	$36.98 - $41.52 $4,622 - $5,190	-125 Reduced 0.22%	56,039 $2.43 Million
Q1 2019 Apr 18, 2019	SELL	$37.5 - $41.2 $116,437 - $127,926	-3,105 Reduced 5.24%	56,164 $2.39 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $191,157 - $217,940	-4,969 Reduced 7.74%	59,269 $2.59 Million
Q3 2018 Oct 31, 2018	BUY	$34.47 - $41.81 $6,894 - $8,362	200 Added 0.31%	64,238 $2.83 Million
Q2 2018 Jul 24, 2018	SELL	$32.98 - $35.16 $98,907 - $105,444	-2,999 Reduced 4.47%	64,038 $2.32 Million
Q4 2017 Jan 29, 2018	SELL	$33.26 - $35.29 $73,172 - $77,638	-2,200 Reduced 3.18%	67,037 $2.43 Million
Q3 2017 Oct 26, 2017	BUY	$31.0 - $34.15 $14,787 - $16,289	477 Added 0.69%	69,237 $2.47 Million
Q2 2017 Aug 14, 2017	BUY	N/A	68,760	68,760 $2.31 Million

Others Institutions Holding PFE

# of Institutions

3,335

Shares Held

3.61B

Call Options Held

104M

Put Options Held

129M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $136B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aull & Monroe Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Aull & Monroe Investment Management Corp with notifications on news.

Account

Aull & Monroe Investment Management Corp Pfizer Inc Transaction History